跳至主要内容
临床试验/NCT02919709
NCT02919709Unknown不适用

Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells

Centre Hospitalier Universitaire de Besancon1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2013年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
progenitor cells CD34+ blood levels

研究概览

简要总结

The study aims to investigate the existence of a reliable correlation between the progression of aortic diameters and blood levels of circulant endothelial progenitor cells CD34+ in patients with not surgical aortic aneurysms.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients aged 18 or more.
  • •Patients diagnosed with a thoracic or abdominal aortic aneurysm with no indication for surgical treatment (diameters > 30 mm but < 50 mm).
  • •Patients accepting to sign a specific informed consent.

排除标准

  • •Unstable coronary artery disease.
  • •Congenital heart disease.
  • •Any evolving infectious syndrome or viral infection (HIV, HBV or HCV).
  • •Any chronic inflammatory or autoimmune disease.
  • •Prior administration of G-CSF; EPO; GM-CSF.
  • •Liver failure.
  • •Prior oncologic disease or ongoing cancer with a life expectancy < 1 year.
  • •Patients aged < 18.

研究组 & 干预措施

thoracic or abdominal aortic aneurysm

Experimental

干预措施: blood taking (Biological)

结局指标

主要结局

progenitor cells CD34+ blood levels

时间窗: 24 month after diagnosis

progenitor cells CD34+ blood levels

时间窗: At diagnosis of aneurysm

progenitor cells CD34+ blood levels

时间窗: 6 month after disgnosis

progenitor cells CD34+ blood levels

时间窗: 12 month after diagnosis

progenitor cells CD34+ blood levels

时间窗: 18 month after diagnosis

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Follow up of Patients With Aortic Aneurysm by Dosage... | 临床试验